Navigation Links
Pacira Pharmaceuticals, Inc. Announces Efficacy and Safety of EXPAREL™ Highlighted at "Hot Topics in Plastic Surgery" Panel at the 2011 Annual Meeting of the American Society of Plastic Surgeons
Date:9/26/2011

relief, so a new therapy like EXPAREL, which blocks the pain at its source for up to three days and potentially reduces the need for opioids, could be a game changer."

Also at ASPS, new data from a two-year observational study of EXPAREL following breast augmentation were presented during an oral session on Saturday, September 24, 2011. The study, a long-term follow-up of 94 subjects enrolled in prior Phase 2 and Phase 3 studies who underwent breast augmentation at multiple sites in the U.S. and received either bupivacaine or EXPAREL, evaluated patients from 13 to 24 months following surgery; new key finding include:

  • EXPAREL did not have any impact on normal healing in the presence of silicone breast implant material.
  • There was no meaningful difference in impact on breast appearance or implant material in the bupivacaine versus EXPAREL groups.
  • Neither EXPAREL nor bupivacaine were associated with any serious adverse events, deaths or withdrawals from the study.

"EXPAREL represents a much needed advance in perioperative, site-specific pain relief therapies, and this study demonstrates the long-term safety profile of EXPAREL following breast augmentation," said Harold Minkowitz, M.D., the study's lead author and a staff anesthesiologist at Memorial Hermann Memorial City Medical Center in Houston, Texas. "After evaluating patients for up to two years after the procedure, we concluded that EXPAREL did not interfere with the patient's healing process or the integrity of the implant material, and was not associated with any late-stage adverse events."

According to the ASPS, breast augmentation has been the most performed cosmetic surgical procedure since 2006. In 2010, approximately 296,000 breast augmentations were performed, 60 percent of which used silicone implants.(1) In the last decade, the number of breast augmentations performed has increased by 39 percent.(1)

"We are
'/>"/>

SOURCE Pacira Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Positive Phase II Study of Paciras EXPAREL(TM) (DepoBupivacaine) in Total Knee Arthroplasty Presented at International College of Surgeons World Congress
2. Positive Phase II Study of Paciras EXPAREL(TM) (DepoBupivacaine) in Hernia Repair Presented at the Postgraduate Assembly in Anesthesiology (PGA)
3. Phase III Studies of EXPAREL(TM) (DepoBupivacaine) from Pacira Complete Enrollment
4. Pacira Pharmaceuticals Announces FDA Acceptance of EXPAREL™ New Drug Application for Pain Management
5. Pacira Pharmaceuticals Presents New Data from EXPAREL Phase 3 Study at Orthopaedic Research Societys 57th Annual Meeting
6. Pacira Pharmaceuticals, Inc. Announces Pricing of Its Initial Public Offering
7. Pacira Pharmaceuticals Highlights Additional Safety Data on EXPAREL™ for Postsurgical Pain Relief at 2011 American Academy of Orthopaedic Surgeons Annual Meeting
8. Pacira Pharmaceuticals EXPAREL™ Data to be Featured at 2011 ASCPT 112th Annual Meeting
9. Pacira Pharmaceuticals to Present at the Barclays Capital 2011 Global Healthcare Conference
10. Pacira Pharmaceuticals Reports Fourth Quarter and 2010 Financial Results
11. Pacira Pharmaceuticals to Present at BioCentury Future Leaders in the Biotech Industry Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2015)... -- Novira Therapeutics, Inc., a privately held, clinical-stage biopharmaceutical company ... B virus (HBV) infection, today announced the presentation of ... candidate, NVR 3-778, at the 2015 annual meeting of ... (EASL) in Vienna, Austria . ... performed in a humanized UPA/SCID mouse model was described ...
(Date:4/27/2015)... BRH Medical, Ltd., today announced ... Notification Application (510k) with the US Food and Drug ... Medical expects feedback from the FDA during the next ... following FDA pre-market clearance. Additional pre-market regulatory filings are ... CEO for BRH Medical, commented, "We are thrilled to ...
(Date:4/27/2015)... 27, 2015 Endo International plc (NASDAQ: ENDP ... results before the open of the U.S. financial markets on ... will host a conference call and webcast at 9:00 a.m. ... access the call is U.S./ Canada (866) ... Please dial in 10 minutes prior to the scheduled start ...
Breaking Medicine Technology:Novira Therapeutics Announces Presentation of Preclinical Antiviral Data for NVR 3-778 at EASL 2Novira Therapeutics Announces Presentation of Preclinical Antiviral Data for NVR 3-778 at EASL 3BRH Medical, Ltd., Announces Filing of a Pre-Market Submission with the US Food and Drug Administration (FDA) for the BRH-A2 Tissue Management System 2
... Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS ) announced today that it ... , before the U.S. financial markets open. , ... Anadys will hold a conference call and webcast on Thursday, July ... its second quarter 2010 financial results and to provide an update on the ...
... SAN DIEGO , July 22 Neurocrine Biosciences, Inc. (Nasdaq: ... financial results after the Nasdaq market closes on Wednesday, July 28, 2010 ... its financial results and provide a Company update Thursday morning, July 29, ... Time ). , , , ...
Cached Medicine Technology:Anadys Pharmaceuticals to Report Second Quarter 2010 Financial Results 2Neurocrine Biosciences Announces Conference Call and Webcast to Report Second Quarter 2010 Financial Results 2
(Date:4/27/2015)... As ISO 27001 has quickly become ... of all sizes and in all industries, Pivot Point ... for ISO 27001 certification. The information security audit firm ... for ISO 27001 certification. Pivot Point's commitment to ISO ... number of Lead Implementers and Auditors the company employs ...
(Date:4/27/2015)... Guided by the extensive work of its community ... collaboration with organizations around the world to identify proven ... essential actions for organizations committed to patient experience ... systems committed to providing the best in experience will:, ... with committed time and focused intent to shape and ...
(Date:4/27/2015)... PHILADELPHIA, PA (PRWEB) April 27, 2015 ... it will exhibit its wide range of market leading ... to May 7 in Geneva, Switzerland. Vitafoods Europe 2015 ... over 100 countries showcasing the latest research in such ... personalized nutrition. , FMC Health and Nutrition’s booth ...
(Date:4/27/2015)... On May 15, Mount Soma Ashram ... campaign to raise awareness of the vision of Mount ... Somesvara Temple. Ironically, when many of these people moved ... thought they were leaving the social and technological world ... of meditation, service to a higher cause, deep introspection, ...
(Date:4/27/2015)... York, NY (PRWEB) April 27, 2015 ... are creating a seamless referral process for the Health ... with chronic heart failure or diabetes, for instance, may ... most primary physicians coordinate with many other care providers. ... referring hundreds of thousands of patients each year, the ...
Breaking Medicine News(10 mins):Health News:Six Additional New ISO 27001 Lead Implementers Certified for Pivot Point Security 2Health News:Guiding Principles for Patient Experience Excellence Identified by The Beryl Institute 2Health News:FMC Health and Nutrition to Feature Epax® Brand Omega-3 Ingredients at Vitafoods Europe 2015 2Health News:Mount Soma Monks Do Social Media 2Health News:Mount Sinai Launches System for Faster Referrals 2Health News:Mount Sinai Launches System for Faster Referrals 3
... American Institute of Ultrasound in Medicine (AIUM) and ... the collaborative development of the Practice Guideline for ... Practice of Urology. This guideline has been developed ... the practice of urology and provides direction in ...
... Molecular Medicine (MDC) Berlin-Buch have found out why the ... the world,s most unusual mammals, feels no pain when ... in narrow dark burrows where ambient carbon dioxide (CO2) ... converted into acid, which continuously activates pain sensors. However, ...
... , TUESDAY, Dec. 20 (HealthDay News) -- Increased public ... reasons why child and teen exposure to unwanted online ... States, a new study indicates. However, reports of ... University of New Hampshire Crimes Against Children Research Center. ...
... "disarray and dysfunction" jeopardize access to medical care ... military families, said the American College of Physicians ... with House and Senate leadership. ACP is ... membership organizationin the United States, representing 132,000 internal ...
... A hike in your blood pressure during middle age significantly ... stroke during your lifetime, according to new Northwestern Medicine research. ... maintaining low blood pressure early in middle age to prevent ... developed high blood pressure in middle age or who started ...
... evaluating early kidney injuries in people, doctors monitor blood ... breakdown, to understand the severity of the injury. Creatinine ... an indication of early damage to vital kidney function. ... Missouri researchers have found that even tiny increases of ...
Cached Medicine News:Health News:MDC researchers: Ion channel makes African naked mole-rat insensitive to acid-induced pain 2Health News:MDC researchers: Ion channel makes African naked mole-rat insensitive to acid-induced pain 3Health News:Youth Exposure to Unwanted Internet Sexual Encounters Drops 2Health News:Congress' 'disarray' makes it 'likely' that 27 percent Medicare cut will go in effect 2Health News:New predictor of heart attack or stroke 2Health News:MU researchers find pet kidney injuries are similar to human kidney injuries 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: